logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Aripiprazole CAS 129722-12-9

Aripiprazole CAS 129722-12-9

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 129722-12-9

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
129722-12-9
Appearance :Appearance ::
White To Off-white Powder
Molecular Formula::
C23H27Cl2N3O2
Molecular Weight::
448.385
EINECS NO::
603-355-5
MDL NO::
MFCD00892072
CAS NO::
129722-12-9
Appearance :Appearance ::
White To Off-white Powder
Molecular Formula::
C23H27Cl2N3O2
Molecular Weight::
448.385
EINECS NO::
603-355-5
MDL NO::
MFCD00892072
Aripiprazole CAS 129722-12-9

Product Description:

Product Name: Aripiprazole CAS NO:129722-12-9

 

 

 

 

 

 

 

Synonyms:

7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone;

7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one;

 

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance :White to Off-white powder

Assay :≥99.0%

Density:1.263 g/cm3

Boiling Point:646.2℃ at 760 mmHg

Melting Point:139℃

Flash Point:344.6℃

 

 

 

 

 

 

 

 

Aripiprazole is a new type of highly fat-soluble quinolinone derivative. Its pharmacological action is characterized as a post-synaptic dopamine D2 receptor antagonist and a presynaptic dopamine D2 receptor agonist. It also has the effect of stimulating D1, D3, and D4 receptors; it has a dual effect of partial receptor antagonism or activation on 5-HT1A receptor; it has a complete antagonistic effect on 5-H Chemicalbook T2A receptor. This feature is different from the first-generation and atypical antipsychotic drugs, that is, the second-generation antipsychotic drugs, so it is called the dopamine system stabilizer or the third-generation antipsychotic drugs. Since the last century, it has been mainly used clinically for the treatment of schizophrenia, schizophrenic emotional psychosis and other psychotic disorders.

 

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.